<DOC>
	<DOCNO>NCT02230319</DOCNO>
	<brief_summary>The purpose study determine cryotherapy effectively decrease rate neuropathy patient undergoing weekly paclitaxel treatment .</brief_summary>
	<brief_title>Prevention Paclitaxel Neuropathy With Cryotherapy</brief_title>
	<detailed_description />
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Inclusion Criteria 1 . Women 18 year age old 2 . Histologically cytological proven diagnosis breast cancer Stage I III . 3 . Must pl receive weekly paclitaxel treatment either adjuvant neoadjuvant setting . 4 . May receive prior treatment include , radiation , surgery chemotherapy hormone biologics . 5 . Eastern Cooperative Oncology Group ( ECOG ) performance status â‰¤ 1 6 . Patient sign informed consent . 7 . Patient willing able comply schedule visit treatment plan . Exclusion Criteria 1 . Patient present Grade 2 great peripheral neuropathy . 2 . History Raynaud 's Disease . 3 . Patient present open poorlyhealing wound hand foot . 4 . Patients cold intolerance . 5 . Patient concurrent severe and/or uncontrolled medical condition would , investigator 's judgment contraindicate patient participation .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Cryotherapy</keyword>
	<keyword>Cold therapy</keyword>
	<keyword>Peripheral Neuropathy</keyword>
	<keyword>Paclitaxel</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Symptom management</keyword>
	<keyword>Prevention</keyword>
</DOC>